4
Changes in Ownership
RenovoRx, Inc. Filed Acc 0001641172-25-005108
Options or other derivatives
- Chief Clinical Officer acquired 26,477 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Gentry Leesa Chief Clinical Officer | 2025-04-14 | Grant or award · Stock Option | +26,477 | 26,477 | D | ||
Loading xslF345X05/ownership.xml…